Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jan 11;57(2):119-27.
doi: 10.1016/j.jacc.2010.08.627.

Obstructive Sleep Apnea and Heart Failure: Pathophysiologic and Therapeutic Implications

Affiliations
Free article
Review

Obstructive Sleep Apnea and Heart Failure: Pathophysiologic and Therapeutic Implications

Takatoshi Kasai et al. J Am Coll Cardiol. .
Free article

Abstract

Obstructive sleep apnea (OSA) exposes the cardiovascular system to intermittent hypoxia, oxidative stress, systemic inflammation, exaggerated negative intrathoracic pressure, sympathetic overactivation, and elevated blood pressure (BP). These can impair myocardial contractility and cause development and progression of heart failure (HF). Epidemiological studies have shown significant independent associations between OSA and HF. On the other hand, recent prospective observational studies reported a significant association between the presence of moderate to severe OSA and increased risk of mortality in patients with HF. In randomized trials, treating OSA with continuous positive airway pressure suppressed sympathetic activity, lowered BP, and improved myocardial systolic function in patients with HF. These data suggest the potential for treatment of OSA to improve clinical outcomes for patients with HF. However, large-scale randomized trials with sufficient statistical power will be needed to ascertain whether treatment of OSA will prevent development of, or reduce morbidity and mortality from HF.

Similar articles

See all similar articles

Cited by 74 articles

See all "Cited by" articles

Publication types

MeSH terms

Feedback